The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 17,478 | 1,261,927 | SH | OTR | 1 | 0 | 1,261,927 | 0 | |
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 16,125 | 2,003,114 | SH | OTR | 1 | 0 | 2,003,114 | 0 | |
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 4,140 | 1,224,968 | SH | OTR | 1 | 0 | 1,224,968 | 0 | |
| IMMUNOGEN INC | COM | 45253H101 | 15,801 | 2,129,531 | SH | OTR | 1 | 0 | 2,129,531 | 0 | |
| MERUS N V | COM | N5749R100 | 24,912 | 783,398 | SH | OTR | 1 | 0 | 783,398 | 0 | |
| OTONOMY INC | COM | 68906L105 | 62 | 30,000 | SH | OTR | 1 | 0 | 30,000 | 0 | |
| PARDES BIOSCIENCES INC | COM | 69945Q105 | 6,574 | 401,593 | SH | OTR | 1 | 0 | 401,593 | 0 | |
| PIERIS PHARMACEUTICALS INC | COM | 720795103 | 1,449 | 383,266 | SH | OTR | 1 | 0 | 383,266 | 0 | |
| THESEUS PHARMACEUTICALS INC | COM | 88369M101 | 5,191 | 409,358 | SH | OTR | 1 | 0 | 409,358 | 0 | |
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | 22,878 | 737,061 | SH | OTR | 1 | 0 | 737,061 | 0 | |